1 / 50

CNS Infections

CNS Infections. ELS Wednesday, August 6th 2008 Amal Al-Hashmi. Outline. Viral meningitis Viral encephalitis Bacterial meningitis Etiology Pathophysiology Clinical Presenation Pathophysiology Diagnostic tools CT, MRI head, LP,EEG Treatment. Viral meningitis. Definition

adonai
Download Presentation

CNS Infections

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. CNS Infections ELS Wednesday, August 6th 2008 Amal Al-Hashmi

  2. Outline • Viral meningitis • Viral encephalitis • Bacterial meningitis • Etiology • Pathophysiology • Clinical Presenation • Pathophysiology • Diagnostic tools • CT, MRI head, LP,EEG • Treatment

  3. Viral meningitis • Definition an inflammatory response to viral infection of leptomeningeal cells and the subarachnoid space • account for the majority, at least 70%, of cases of aseptic meningitis

  4. Etiology • In Europe and US nonpolio enteroviruses are the most common case of viral meningitis ( Kupila et al 2006) for both children & adults (coxsackie & enteric cytopathogenic human orphan virus [echovirus]), are the most common causal agents

  5. Etiology followed by mumps arboviruses herpesviruses lymphocytic choriomeningitis HIV at the time of seroconversion

  6. Clinical presentation • Children under 2 years of age show fever, irritability, or seizures , but may never develop signs of meningeal irritation • Adult pts present with fever, malaise, headache, nausea, vomiting, nuchal rigidity, & photophobia

  7. CSF 1- slightly elevated opening pressure 2- mild to moderate pleocytosis with 10–500 white blood cells (WBC)/µl, predominantly lymphocytes 3- mildly elevated protein (<100 mg/dl), 4- normal glucose

  8. CSF • RT-CRP has now replaced viral cultures as diagnostic procedure of choice for establishing enteroviral infections ( Ramers et al 2000) • computed tomography or magnetic resonance imaging (MRI) scans in general are normal

  9. Viral Encephalitis • Etiology • C/F • CSF findings • Neuroimaging

  10. Viral Encephalitis • Most common cause are herpes simplex and arboviruses • HSV-1 most common cause of fetal encephalitis in US accounting for 10% overall& 90% in adult frequency 1/250,000 • HSV-2 more commonly isolated in monophasic or recurrent meninigitis & congenitally acquired neonatal HSV meningoencephalitis

  11. Viral Encephalitis • C/F Fever 90% Headache 80% Altered mentation 70% Personality changes 70-80% Seizures 40-67% Memory disturbance 25-45% Motor deficit 30-40% Aphaisa 33% Olfactory hallucination

  12. Viral Encephalitis • No set of signs or symptoms is pathognomonic of HSE (Whitly 2006)

  13. CSF • increased opening pressure • Normal glucose • Moderalty elevated protien • Lymphocytic pleocytosis 10-1000/microlitter • Xanthochromia and red cells may occur • Cultures negative in 95%

  14. CSF • PCR of HSE is the diagnostic procedure of choice ( lakeman & whitely 1995) • False negative ( Weil et al. 2002)

  15. Neuroimaging • particularly MRI,may show temporal or orbitofrontal cortex enhancement or edema in HSE ( Raschilas et al 2002) • In most other acute viral encephalitis, neuroimaging findings are nonspecific • Brain MRI or CT serve to exclude brain abscess, subdural empyema, cranial extradural abscess, or septic venous thrombosis

  16. EEG • Diffuse slowing • Focal abnormalities in the temporal region ( 75% with +ve PCR) • PLEDS

  17. Brain Biopsy • Atypical cases • Poor response to treatment • Findings: hemorrahgic necrosis HSV antigen in infected neurons acidophilic intranuclear inclusions

  18. Treatment • Empiric therapy with acyclovir should be started immediately • Stander Rx course is IV acyclovir 10mg/kg Q8h in adults 20mg/kg Q8h in neonate and children • Duration 14-21 days

  19. Treatment • Steroid ? Retrospective studies suggested no obvious harm and be some benefit ( Kamie et al 2006) Controlled clinical trails are needed

  20. Prognosis • Mortality rate in untreated cases is 70% which reduced to 19-27%with rx • Morbidity remains high only 37% of all pt PCR proven and treated with acyclovir survive with no or mild residual deficits (Raschilas et al2002)

  21. Prognosis • Clinical relapse can occur and more often in children and neonate • Consider Foscarnet in cases of acyclovir resistant stains or in who are allergic

  22. Bacterial meningitis • Incidence of 3-5/100 000/year in US (quagliarello 1997) • More than 1500 death/yr in US

  23. Etiology - General • Pneumococcus (Streptococcus Pneumoniae) • Most common in adults >20 • Account for ½ of reported cases • 2° to pneumonia/otitis, splenectomy/DM2 • ’ing incidence of pen-resistance in pneumococcus (25-45% to pen, 10% to Ceph,+ to chloramphenicol)

  24. Etiology - General • HiB (Haemophilus Influenzae type B) • Before vaccination, most common case in US 45% of meningitis caused by Hib • Now accounts for less than 10%– • still in elderly, HIV pts

  25. Etiology - General • Meningococcus (Neisseria Meningitidis) • Mainly children and young adults (army/college) • 2° to asymptomatic nasopharyngeal colonization

  26. Etiology – Special Populations • Neonate • GBS, E. coli & other gram neg., Listeria (10%) • Post head trauma/Neurosurgery • Staph Aureus & CNS, Enteric gram neg. • Elderly • Listeria and Hib • Listeria = Impaired cellular immunity • Pregnancy, Chronic disease, Elderly, Alcohol

  27. Clinical Presentation • Triad of Headache, fever and neck stiffness: 85% of patients • N/V, photophobia, myalgia ( common) • Alteration in LOC, Seizures (40%) • Nuchal rigidity: resistance to passive flexion • Kernig’s: extension of the knee with thigh flexed pain, neck flexion • Brudzinsky’s • Flexion of neck causes hip flexion

  28. Clinical Presentation • Cranial nerve palsies 3rd, 6th , 7th (10-20%) • Occasionally focal neurological deficit hemiparesis, dysphasia

  29. Clinical Presentation • Classical c/f are commonly absent in neonates look for high pitched crying, refusal to feed, irritability • In elderly less act onset of lethrgy, mild or no fever

  30. Certain clinical features • Promient rash particually extrimities (Meningococcus) erythemaous, macular evolving into petechial • Rhinorrhea or otorrhea with S pneumoniae

  31. Pathophysiology • Bacteria spread by droplets and colonize nasopharynx • bacteremia then meningeal spread thru chroroid plexus epithelial cells • Multiply rapidly because of absence of immune cells • Lysis of bacterial cell wall in SAS • Stimulate microglia inflammatory cytokine production of IL-1 and TNF

  32. Roos, seminars in neurology 2000

  33. Pathophysiology • Alteration of BBB w/ vasogenic edema + loss of autoregulation AND entry of PMN w/ cytotoxic edema SO formation of purulent exudate  Hydrocephalus  narrows arteries in SAS and invades wall (vasculitis; leads to CVA)  Continous rise of ICP and coma

  34. CSF • ↑ pressure 20-50 mm H20 • ↑ WBC (100-10000 wbc/mm3, mainly PMN) • ↓ glucose (less than 40% of serum glu) • ↑ Protein (1.0-5.0 mg/dl) • Positive gram stain/culture in 70-90% • Less if Abx before; sterile only after 12h • Bx if skin lesions

  35. Diagnosis • Blood Cultures (50%) • Abx before LP if CT/LP delay Tx (no change in WBC +/- in sterility for hours) • +/- Decadron • CT head (?) • Lumbar Puncture

  36. CT Head before LP? • CT will be abnormal, if you have : • Seizure • clinical evidence of increased ICP • Hx of CNS disease • Immuncompromised status • Age>60 • Abnormal neurological exam (including mental status) Hasbun et al. CT head before LP in suspected meningitis. NEJM 345:1727, 2001 Kastenbauer et al. CT head before LP in suspected meningitis. NEJM 346:1248, 02

  37. CT SCAN PRIOR TO LUMBAR PUNCTURE IN SUSPECTED MENINGITIS • 235 patients with suspected meningitis underwent CT • 56/235 (24%) had abnormal CT; 11 (5%) with mass effect Hasbun et al. NEJM 2001;345:1727.

  38. CT SCAN PRIOR TO LUMBAR PUNCTURE IN SUSPECTED MENINGITIS • 96 patients without above features who underwent CT • 93 had normal CT; 1 had mass effect • All had lumbar puncture with no evidence of brain herniation Hasbun et al. NEJM 2001;345:1727.

  39. CT before LP • Kastenbauer: Nothing predicts herniation (Abnormal CT in 2/10 herniations and 27/65 w/ no herniation) of Kastenbauer et al. N Engl J Med 2002;346(16):1248-1251. (189K)

  40. Treatment

  41. Treatment • Based on age • Always bactericidal • Consider intrathecal Vanco • Alternatives: • Cefepime or meropenem instead of 3rd generation Ceph • If severe Pen allergy: Vanco + chloramphenicol or Vanco + septra (listeria) • 3rd generation Cephalosporin • Ceftriaxone 2g q12h – jaundice in neonates • Cefotaxime 2g q4h • Ceftazidime 2g q 8h

  42. Tx of contacts • Contact Public Health for meningococcus and HiB • Need to treat close contacts (potentially share secretions) • Rifampin bid for two days C • Or Cipro 500mg once • Or zithromax 500mg once

  43. Prevention • Pneumovax for surgical or functional asplenia (sickle cell, chronic illness, immunosuppression, older age…)

  44. Steroids • Morbidity and mortality of meningitis related of inflammatory reaction rather than bacteria themselves • Decadron inhibits IL-1 and TNF m-RNA production and  CSF outflow resistance and stabilizing BBB • Lots of small studies 1950’s-2002; big studies are rare, especially in adults.

  45. Steroid • The available evidence on adjunctive dexamethasone therapy confirms a benefit for treating H influenza type b in reducing audiological sequelae and suggest benefit in reducing the audiological and neurological sequelae in H influenza type b and pneumococcal in children • (sebire et al 2006) …….( weisfelt et al 2006)

  46. Cochrane Review 2003 • 18 RCT • Mainly kids • General • Lower mortality RR 0.76 [.59-.98] • Hearing loss 0.36 [.22-.60] • Neuro Sequelae 0.66 [.44-.99] • In Children • Lower hearing loss in non Hib meningitis 0.42 [.2 - .89] • In adults • Lower mortality 0.48 [0.24-0.96]

  47. Systematic Review in adults • 5 RCT in adults • Overall mortality and neuro sequelae 0.6 • Pneumococcus mortality 0.5 • Meningococcal sequelae 0.5 and mortality 0.9 • No increased side effects with steroids

  48. Vanco level controversy • Experimental evidence of decreased absorption if steroids given • One RCT study in children demonstarted reliable penetration of vanco if 60mg/kg doses used. • 4/11 pts in adults failed vanco with steroids but used lower dosages

  49. Steroids Do not use if immunosuppressed

  50. Thank You! Questions?

More Related